Dr. Moises Roizental: All About Weight Management and Obesity Medication: GLP 1 Agonists
Know Your Physio
English - December 22, 2022 16:00 - 41 minutes - 28.8 MB - ★★★★★ - 42 ratingsHealth & Fitness health fitness longevity performance productivity biohacking science education Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
The ever-increasing issue of obesity and its related health complications brings with it the need for effective treatment. We are joined today by a board-certified vascular and interventional radiologist, Dr. Moises Roizental, to talk all things weight loss and obesity medication (specifically GLP-1 agonists). Dr. Roi explains the challenge of overcoming obesity and the role GLP-1 agonists play in alleviating the struggle. We learn about the multitude of benefits, obesity-related and otherwise, as well as the indications, contraindications, and side effects. Tune in to hear about the long-term benefits of investing in your health and how to get the best results from this life-changing medication!
Key Points From This Episode:
What “bioavailability” means. [00:22]Introducing vascular and interventional radiologist, Dr. Moises Roizental. [03:13]Introducing today’s topic: weight loss and obesity medication. [03:39]Where to find the Spanish version of this episode. [04:23]What GLP-1 agonists are, how they work, and their metabolic benefits. [05:59]The weight loss results of GLP-1 agonists. [11:22]What to pair the meds with to see results. [11:38]Other non-obesity-related benefits of the medication. [12:09]The history of the medication. [14:21]Under which circumstances GLP-1 agonists are contraindicated. [15:15]How GLP-1 agonists alleviate the challenge of overcoming obesity. [16:47]Dr. Roi’s personal experimentation with the medication. [18:53]The availability and accessibility of the meds. [20:39]Some of the long-term benefits of investing in your health. [21:51]The side effects of GLP-1 agonists. [23:49]Controversial use/abuse of the medication. [24:54]The recommended dosage of GLP-1 agonists. [27:29]Dr. Roi’s advice for those interested in exploring this medication. [30:11]Safe sources of GLP-1 agonists. [34:04]Dr. Roi’s for the future of GLP-1 agonists. [35:45]Why Dr. Roi has shifted from intervention towards disease prevention. [37:06]Links Mentioned in Today’s Episode:
Dr. Moises Roizental on LinkedIn
Dr. Moises Roizental on Twitter
Dr. Moises Roizental on Instagram
Hambre y Hormonas on Instagram